AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16497598
Drug: Placebo patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patch + stimulant medication
Trial: 16497598
Drug: Placebo patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patch only
Trial: 16497598
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch administration
Trial: 10606836
Drug: Tolcapone (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolcapone (50, 200 or 400 mg three times daily)
Trial: 9180124
Drug: High intensity
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High intensity exercise training (2 h of walking daily and four weekly sessions of high intensity monitored stationary cycling for 2 months)
Trial: 1336886
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg epinephrine
Trial: 3005138
Drug: Pectin (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pectin (12 g/day)
Trial: 3005138
Drug: Cellulose (15
RxNorm normalized name: methylcellulose (15 CPS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cellulose (15 g/day)
Trial: 3005138
Drug: Lignin (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignin (12 g/day)
Trial: 29981576
Drug: Oxytocin administration
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin administration (30 IU in 1000 mL of Ringer's serum, max rate of 10 mL/min)
Trial: 21373936
Drug: Lowering pCO(2)
RxNorm normalized name: Calendula Flower
DrugBank: Calendula officinalis flower (DB14263)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lowering pCO(2) therapy
Trial: 21373936
Drug: Raising pCO(2)
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raising pCO(2) therapy
Trial: 16644317
Drug: Standard periodontal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard periodontal therapy
Trial: 12809583
Drug: Isoniazid 300
RxNorm normalized name: isoniazid 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoniazid 300 mg once daily (Group 1)
Trial: 12809583
Drug: Isoniazid 900
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid 900 mg/twice weekly (Group 2)
Trial: 10852265
Drug: Thalidomide (initially
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide (initially 100 mg daily, reduced to 50-25 mg daily for maintenance)
Trial: 1739629
Drug: Carboplatin 400
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin 400 mg m‐2 alone (Arm A)
Trial: 1739629
Drug: Carboplatin 300
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin 300 mg m‐2 with chlorambucil 10 mg day‐1 for 7 days (Arm B)
Trial: 6748722
Drug: Reperfusion solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reperfusion solution (1 L delivered just prior to removal of the aortic clamp)
Trial: 23662599
Drug: Firocoxib chewable
RxNorm normalized name: firocoxib Chewable Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Firocoxib chewable preparation
Trial: 23088336
Drug: Lopinavir/ritonavir (LPV/r)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lopinavir/ritonavir (LPV/r) 800/200 mg
Trial: 23088336
Drug: Once-daily darunavir/ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily darunavir/ritonavir (DRV/r)
Trial: 16391473
Drug: Cholinesterase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholinesterase inhibitors (specific drugs not mentioned)
Trial: 15288412
Drug: i.v. fentanyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. fentanyl plus low dose i.v. ketamine (group 1)
Trial: 15288412
Drug: Pre-operative low-dose
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative low-dose i.v. ketamine (group 1)
Trial: 7969342
Drug: Parathyroid hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Parathyroid hormone (40 micrograms subcutaneously daily)
Trial: 7969342
Drug: Nafarelin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nafarelin (200 micrograms intranasally twice daily)
Trial: 7969342
Drug: Nafarelin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nafarelin plus parathyroid hormone
Trial: 3326689
Drug: Bay‐m‐1099 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bay‐m‐1099 (50 mg)
Trial: 27060152
Drug: SMILE (dexamethasone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SMILE (dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide)
Trial: 8909331
Drug: Nadolol 120
RxNorm normalized name: nadolol 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol 120 mg/day
Trial: 30855442
Drug: Sequential acupoint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential acupoint stimulation
Trial: 29741592
Drug: SAFE (surgery,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAFE (surgery, antibiotics, facial cleanliness, and environmental improvement) interventions
Trial: 25682077
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg daily for 1 week then 1 g twice daily for a further week)
Trial: 25682077
Drug: Control (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (not receiving metformin)
Trial: 20975299
Drug: 4 weeks
RxNorm normalized name: risperiDONE 75 mg/4 weeks intramuscular powder for injection, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 weeks of physical training with antioxidants (vitamin C 1,000 mg/day and vitamin E 400 IU/day)
Trial: 15957827
Drug: Compound periploca
RxNorm normalized name: Periploca sepium root bark extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound periploca liquid (CPL)
Trial: 15957827
Drug: Periploca syrup
RxNorm normalized name: Periploca sepium root bark extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periploca syrup
Trial: 2031815
Drug: Atracurium 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 0.2 mg kg‐1 with previous suxamethonium 1 mg kg‐1
Trial: 2031815
Drug: Atracurium 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 0.2 mg kg‐1 without previous suxamethonium
Trial: 6382991
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 to 240 mg twice a day)
Trial: 6382991
Drug: Verapamil (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (120 to 240 mg twice a day)
Trial: 30202883
Drug: Nicorette 4
RxNorm normalized name: Nicorette 4mg Lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorette 4 mg nicotine gum (NG)
Trial: 20678689
Drug: Intranasal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal fentanyl 0.05 mg/0.1 mL
Trial: 20678689
Drug: Placebo (preserved
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (preserved normal saline) 0.1 mL
Trial: 20805137
Drug: Amniotic membrane
RxNorm normalized name: Amniotic Membrane Human Ophthalmic Sheet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amniotic membrane transplantation (AMT) in addition to conventional medical therapy
Trial: 16193890
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose oral methylprednisolone
Trial: 11890187
Drug: 30 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/day mianserin (n = 9)
Trial: 29795314
Drug: Rescue antenatal
RxNorm normalized name: ALLERGENIC EXTRACT, MEADOW FESCUE POLLEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue antenatal steroids (ideal treatment)
Trial: 29795314
Drug: Rescue antenatal
RxNorm normalized name: ALLERGENIC EXTRACT, MEADOW FESCUE POLLEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue antenatal steroids (remote treatment)
Trial: 25582493
Drug: Cisplatin 75
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 75 mg/m² and pemetrexed 500 mg/m², every 3 weeks for 6 cycles followed by maintenance pemetrexed
Trial: 25582493
Drug: Carboplatin AUC
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin AUC 6, paclitaxel 200 mg/m², and bevacizumab 15 mg/kg, every 3 weeks for 6 cycles followed by maintenance bevacizumab
Trial: 10847254
Drug: Warfarin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin therapy with INR > 6.0
Trial: 8664133
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate (MA) at 160 mg day‐1
Trial: 8664133
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate (MA) at 320 mg day‐1
Trial: 8664133
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate (MA) at 320 mg day‐1 (further therapy)
Trial: 8664133
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate (MA) at 480 mg day‐1 (further therapy)
Trial: 6740497
Drug: Anti-estrogen therapy
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-estrogen therapy (tamoxifen, Nolvadex) added to chemotherapy (cyclophosphamide, methotrexate, and fluorouracil - CMF)
Trial: 6740497
Drug: Nonspecific immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonspecific immunotherapy with bacillus Calmette-Guerin
Trial: 29969366
Drug: Children with
RxNorm normalized name: Pediaclear Childrens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Children with ALL treatment
Trial: 29604548
Drug: Non-ablative Er:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ablative Er:YAG laser therapy
Trial: 25304789
Drug: Synbiotic powder
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic powder containing Lactobacillus reuteri 10(8) CFU and 4.3 g of soluble fiber
Trial: 17852417
Drug: Intravenous pregnanolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pregnanolone (3alpha-hydroxy-5beta-pregnan-20-one) during E2-only withdrawal
Trial: 17852417
Drug: Intravenous pregnanolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pregnanolone (3alpha-hydroxy-5beta-pregnan-20-one) during withdrawal from E2 + P
Trial: 7714935
Drug: Antimicrobial therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial therapy (nalidixic acid)
Trial: 7714935
Drug: Ineffective antimicrobial
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ineffective antimicrobial therapy
Trial: 2665385
Drug: Mictonorm (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mictonorm (45 mg/d)
Trial: 2665385
Drug: Spasuret (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spasuret (300 mg/d)
Trial: 20917
Drug: Clobazam (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobazam (10 mg)
Trial: 1234503
Drug: Clobazam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobazam (20 mg)
Trial: 20917
Drug: Triflubazam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triflubazam (20 mg)
Trial: 20917
Drug: Triflubazam (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triflubazam (40 mg)
Trial: 31482784
Drug: Vaccine awareness
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine awareness
Trial: 17570424
Drug: Tolterodine ER
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine ER (4 mg QD)
Trial: 9079242
Drug: Test preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test preparation (250 mg flutamide)
Trial: 9079242
Drug: Reference preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference preparation (250 mg flutamide)
Trial: 8485068
Drug: Isradipine 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine 1.25 mg bid for 4 weeks
Trial: 8485068
Drug: Isradipine 2.5
RxNorm normalized name: isradipine 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine 2.5 mg bid for 4 weeks (if needed)
Trial: 8485068
Drug: Isradipine (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (1.25 mg bid)
Trial: 2875003
Drug: Methylprednisolone sodium
RxNorm normalized name: methylPREDNISolone sodium phosphate
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone sodium succinate (MPSS) 30 mg/kg intravenous (maximum dose 3 g)
Trial: 24658627
Drug: Lenvatinib 32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenvatinib 32 mg
Trial: 20075789
Drug: Transthoracic echocardiography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transthoracic echocardiography (TTE) with tri-iodothyronine +/- methylprednisolone therapy
Trial: 20075789
Drug: Thyroid status
RxNorm normalized name: Thyroid
DrugBank: Thyroid, porcine (DB09100)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroid status and hormonal therapy
Trial: 14685056
Drug: TMC125 monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMC125 monotherapy
Trial: 14685056
Drug: Five-drug regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five-drug regimen (zidovudine, lamivudine, abacavir, indinavir, nevirapine)
Trial: 10590488
Drug: Electrophysiologically guided
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrophysiologically guided antiarrhythmic drug therapy
Trial: 1308377
Drug: EMLA occluded
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA occluded with Orahesive Oral Bandages
Trial: 6589647
Drug: Triamterene 200
RxNorm normalized name: Triamterene
DrugBank: Triamterene (DB00384)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamterene 200 mg/d
Trial: 6589647
Drug: Amiloride 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiloride 15 mg/d
Trial: 6589647
Drug: Acetazolamide 750
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetazolamide 750 mg/d
Trial: 3539032
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of inhaled and oral salbutamol
Trial: 3539032
Drug: Inhaled dry
RxNorm normalized name: Dry Powder Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled dry powder of salbutamol
Trial: 12436150
Drug: Ondansetron (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (8 mg)
Trial: 26571889
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (massage therapy + magnetic sticking therapy at auricular points)
Trial: 26571889
Drug: Simple massage
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple massage therapy
Trial: 23127919
Drug: Inactivated virus
RxNorm normalized name: covid-19, inactivated virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated virus vaccine (one dose)
Trial: 23127919
Drug: Inactivated virus
RxNorm normalized name: covid-19, inactivated virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated virus vaccine (two doses)
Trial: 23127919
Drug: MLV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MLV vaccine
Trial: 23127919
Drug: Inactivated virus
RxNorm normalized name: covid-19, inactivated virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated virus vaccine (one or two doses)
Trial: 21558878
Drug: Simvastatin +
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin + Ezetimibe (40 mg/d + 10 mg/d)
Trial: 21558878
Drug: Simvastatin +
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin + Placebo (40 mg/d + placebo)
Trial: 16579803
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (5000 or 10,000 iu daily)
Trial: 12548041
Drug: Low-dose dobutamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dobutamine stress 99mTc tetrofosmin (DSTF) quantitative gated SPECT
Trial: 11508317
Drug: Grape Seed
RxNorm normalized name: grape seed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grape Seed Extract (GSE) 100 mg bid
Trial: 11508317
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Cr and GSE (200 microg Cr and 100 mg GSE bid)
Trial: 9124549
Drug: Lisinopril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (5 mg)
Trial: 9124549
Drug: AVP infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AVP infusion after lisinopril
Trial: 1326902
Drug: gamma-hydroxybutyric acid
RxNorm normalized name: gamma-Hydroxybutyric acid
DrugBank: gamma-Hydroxybutyric acid (DB01440)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gamma-hydroxybutyric acid (50 mg/kg/day, divided into three daily doses)
Trial: 31975413
Drug: Dexmedetomidine 1
RxNorm normalized name: DEXMEDETOMIDINE 120MCG SUBLINGUAL FILM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 1 mcg/kg bwt
Trial: 31975413
Drug: Romifidine 20
RxNorm normalized name: romifidine
DrugBank: Romifidine (DB11543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Romifidine 20 mcg/kg bwt
Trial: 24831977
Drug: Ipilimumab 10
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab 10 mg/kg every 3 weeks for up to four doses, with maintenance therapy every 3 months until disease progression, unacceptable toxic effect, or death.
Trial: 25907621
Drug: Placebo every
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo every 3 weeks for up to four doses, with maintenance therapy every 3 months until disease progression, unacceptable toxic effect, or death.
Trial: 20464778
Drug: Heliox-powered nebulized
RxNorm normalized name: Helixate
DrugBank: Antihemophilic factor, human recombinant (DB00025)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heliox-powered nebulized albuterol
Trial: 20464778
Drug: Air/oxygen-powered nebulized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air/oxygen-powered nebulized albuterol (placebo)
Trial: 18824462
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg simvastatin monotherapy
Trial: 18824462
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg simvastatin and 10 mg ezetimibe combination therapy
Trial: 16000605
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (platinum-based)
Trial: 12794583
Drug: Topical nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical nifedipine
Trial: 12794583
Drug: Topical glyceryl
RxNorm normalized name: glyceryl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical glyceryl trinitrate
Trial: 9927017
Drug: High carbohydrate
RxNorm normalized name: High carbohydrate food
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High carbohydrate diet (5.03 g CHO x kg BM(‐1))
Trial: 9927017
Drug: Moderate carbohydrate
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate carbohydrate diet (3.89 g CHO x kg BM(‐1))
Trial: 7778023
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of M-PLA2, PMN-E, and t-PA
Trial: 31734334
Drug: Twice-daily GSP301
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily GSP301 (olopatadine 665 μg and mometasone 25 μg)
Trial: 31734334
Drug: Once-daily GSP301
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily GSP301 (olopatadine 665 μg and mometasone 50 μg)
Trial: 31734334
Drug: Twice-daily olopatadine
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily olopatadine (665 μg)
Trial: 31734334
Drug: Mometasone monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mometasone monotherapy (twice-daily 25 μg or once-daily 50 μg)
Trial: 31734334
Drug: Twice-daily mometasone
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily mometasone